≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Pure hyperglyceridaemia

DOID EFO Endpoint Browser PheWeb

E4_HYPERGLYCER

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — E78.1
  • Hospital discharge: ICD-9 — 2721
  • Cause of death: ICD-10 — E78.1
  • Cause of death: ICD-9 — 2721

2 out of 7 registries used, show all original rules.

820

4. Check minimum number of events

None

820

5. Include endpoints

None

820

6. Filter based on genotype QC (FinnGen only)

820

Control definitions (FinnGen only)

Control exclude
E4_METABOLIA

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E78
Name in latin
Hypertriglyceridaemia pura

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 5770 2211 3519
Only index persons 5271 2040 3231
Unadjusted period prevalence (%)
Whole population 0.08 0.06 0.10
Only index persons 0.10 0.07 0.12
Median age at first event (years)
Whole population 60.41 67.97 55.72
Only index persons 60.07 67.69 55.26

-FinnGen-

Key figures

All Female Male
Number of individuals 820 299 521
Unadjusted period prevalence (%) 0.18 0.10 0.23
Median age at first event (years) 58.05 60.22 56.81

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
743
Matched controls
7429
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E78.11
ICD-10 Finland
Other hypertriglyceridemia
6357.2
323.0
454
*
E78.10
ICD-10 Finland
Familial hypertriglyceridemia
2817.7
238.8
218
*
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
14.9
166.0
306
333
C10AB05
ATC
fenofibrate; oral
69.1
150.3
171
32
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
6.5
107.3
358
931
E78.1
ICD-10 Finland
Pure hyperglyceridaemia
145.8
96.7
101
8
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
19.3
92.6
145
92
C10AA01
ATC
simvastatin; oral
4.8
88.4
472
1964
C10AA05
ATC
atorvastatin; oral
4.9
88.1
443
1729
103
Kela drug reimbursment
Diabetes, insulin-treated
5.0
83.0
362
1196
A10BA02
ATC
metformin; oral
4.8
81.9
371
1270
215
Kela drug reimbursment
Diabetes, non-insulin-treated
5.0
80.8
334
1034
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
73.8
80.6
91
14
I10
ICD-10 Finland
Essential (primary) hypertension
4.4
73.4
552
2949
C10AA07
ATC
rosuvastatin; oral
4.4
64.0
291
943
A10AE04
ATC
insulin glargine; parenteral
7.1
60.5
162
282
T90
ICPC
Diabetes non-insulin dependent
4.1
58.3
292
1017
E78.29
ICD-10 Finland
Other mixed hyperlipidaemia
209.3
56.9
58
*
C10AX09
ATC
ezetimibe; oral
6.2
53.0
157
309
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
9.6
49.6
106
127
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
6.1
49.0
146
287
C10AB02
ATC
bezafibrate; oral
41.4
49.0
61
16
B01AC04
ATC
clopidogrel; oral
4.6
48.7
193
524
C07AB07
ATC
bisoprolol; oral
2.9
42.7
421
2286
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
8.5
42.5
97
129
A10BK03
ATC
empagliflozin; oral
6.3
41.0
116
211
I25.1
ICD-10 Finland
Atherosclerotic heart disease
3.4
39.2
230
860
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
6.1
39.1
114
215
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
8.4
38.5
88
117
A10BH01
ATC
sitagliptin; oral
4.9
37.2
134
322
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
3.3
37.1
226
862
C03CA01
ATC
furosemide; systemic
3.0
36.9
277
1226
E66.00
ICD-10 Finland
Metabolic syndrome
6.7
36.4
97
162
2721X
ICD-9 Finland
Disorders of lipoid metabolism, Pure hyperglyceridaemia[HYPERTRIGLYCERIDAEMIA ALIA]
+∞
35.7
34
*
SPAT1262
SPAT
Handing over of treatment supplies
3.4
35.5
209
775
C10AB04
ATC
gemfibrozil; oral
35.0
33.5
43
13
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
3.4
33.4
191
689
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
32.9
388
2212
AN1
HP
Coronary angiography
4.1
32.7
140
396
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
3.1
32.6
224
918
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
23.9
31.7
45
20
C08CA01
ATC
amlodipine; oral
2.6
31.6
318
1647
A10BJ02
ATC
liraglutide; parenteral
11.8
30.5
57
52
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
24.6
29.9
42
18
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.7
29.3
266
1284
C01DA14
ATC
isosorbide mononitrate; oral
3.5
29.2
152
505
E66.01
ICD-10 Finland
Obesity due to excess calories
5.5
29.0
90
181
A10BJ06
ATC
semaglutide; parenteral
9.3
28.8
61
71
C09AA05
ATC
ramipril; oral
2.7
28.1
237
1092
E11
ICD-10 Finland
Type 2 diabetes mellitus
3.2
27.7
169
630
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.9
27.6
193
790
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
4.1
27.5
114
311
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
8.8
27.1
59
72
205
Kela drug reimbursment
Chronic hypertension
2.5
26.7
264
1325
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
4.7
26.6
95
223
M04AA01
ATC
allopurinol; systemic
3.3
26.5
152
541
AA1AD
NOMESCO Finland
CT of head and brain
2.7
25.5
211
951
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
5.1
25.3
84
182
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
4.5
24.9
94
233
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.7
24.8
197
864
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
8.7
24.3
53
65
G47.3
ICD-10 Finland
Sleep apnoea
2.6
24.2
210
969
R07.4
ICD-10 Finland
Chest pain, unspecified
2.5
22.9
229
1139
M10.9
ICD-10 Finland
Gout, unspecified
4.3
22.6
88
225
A10BH05
ATC
linagliptin; oral
5.4
21.8
67
133
A10BB12
ATC
glimepiride; oral
4.0
21.8
91
248
I20.09
ICD-10 Finland
Unstable angina
5.0
21.1
70
152
81
HP
Angiography of the heart and coronary arteries
4.6
20.9
76
181
AN4
HP
Balloon angioplasty and drug eluding stent
7.5
20.9
50
71
A10AE05
ATC
insulin detemir; parenteral
4.9
20.9
70
153
C07AB02
ATC
metoprolol; systemic
2.5
20.6
185
859
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
5.2
20.5
65
134
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
20.1
147
606
N03AX16
ATC
pregabalin; oral
2.4
19.5
201
1000
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
6.1
19.3
53
92
I20.01
ICD-10 Finland
Unstable angina
7.7
19.3
45
62
C09AA02
ATC
enalapril; systemic
2.4
19.0
183
879
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.7
19.0
141
586
A02BC02
ATC
pantoprazole; systemic
2.0
18.8
484
3554
XF400
NOMESCO Finland
ECG with 12 standard connections
2.6
18.3
148
645
N02BE01
ATC
paracetamol; systemic, rectal
2.4
18.1
628
5186
I50.9
ICD-10 Finland
Heart failure, unspecified
2.8
18.1
125
493
E86
ICD-10 Finland
Volume depletion
33.8
18.0
23
7
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
4.7
18.0
62
140
L28
ICPC
Limited function/disability (L)
2.7
17.5
134
564
I25.2
ICD-10 Finland
Old myocardial infarction
3.9
17.3
74
206
C10AA04
ATC
fluvastatin; oral
3.4
17.0
87
280
B04AC04
ATC
NA
26.3
17.0
23
9
N03AX12
ATC
gabapentin; oral
2.6
16.9
134
575
M10.0
ICD-10 Finland
Idiopathic gout
5.4
16.8
51
100
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
16.7
260
1540
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
3.3
16.6
87
285
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
3.1
16.6
95
332
A10BX01
ATC
guar gum; systemic
5.3
16.6
51
102
C03DA01
ATC
spironolactone; oral
3.0
16.5
99
358
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
16.3
229
1297
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.8
16.3
115
459
I20.90
ICD-10 Finland
Angina pectoris, unspecified
5.9
16.1
45
80
N02AX02
ATC
tramadol; systemic, rectal
1.9
16.0
329
2164
177
Kela drug reimbursment
Insulin glargine 300 U / ml
10.1
15.8
31
32
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.4
15.7
147
687
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
15.6
166
828
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
4.3
15.6
58
142
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
5.1
15.5
49
101
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.3
15.3
81
268
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.5
15.1
72
219
A10BK01
ATC
dapagliflozin; oral
4.3
15.0
56
138
A10BB01
ATC
glibenclamide; oral
4.5
14.8
53
125
Z01.8
ICD-10 Finland
Other specified special examinations
2.2
14.8
167
854
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
13.6
14.8
25
19
N17.9
ICD-10 Finland
Acute renal failure, unspecified
5.4
14.8
44
85
C08CA13
ATC
lercanidipine; oral
2.6
14.7
119
515
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
7.8
14.5
33
44
R42
ICD-10 Finland
Dizziness and giddiness
2.2
14.4
163
834
R06.0
ICD-10 Finland
Dyspnoea
2.1
14.4
187
1017
160
Kela drug reimbursment
exenatide
7.6
14.3
33
45
E78.49
ICD-10 Finland
Other hyperlipidaemia
27.8
14.3
19
7
H02AB06
ATC
prednisolone; systemic
1.9
14.3
343
2352
C03AA03
ATC
hydrochlorothiazide; oral
3.1
14.2
81
282
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
12.3
14.2
25
21
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
4.8
14.1
47
103
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.0
13.9
225
1334
TPH07
NOMESCO Finland
Cathetrisation of artery
2.9
13.9
89
335
J01DB01
ATC
cefalexin; oral
2.0
13.8
596
4969
211
Kela drug reimbursment
Severe hereditary disorders of lipid metabolism (familial hypercholesterolaemia and type III dyslipoproteinemia)
76.6
13.6
15
*
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
4.1
13.6
54
141
B04AC02
ATC
NA
34.7
13.5
17
5
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.8
13.5
58
163
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.3
13.4
137
667
E87.6
ICD-10 Finland
Hypokalaemia
14.1
13.3
22
16
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
3.7
13.3
59
170
C10AA03
ATC
pravastatin; oral
3.5
13.3
64
197
I20.99
ICD-10 Finland
Angina pectoris, unspecified
3.4
13.3
65
203
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
4.7
13.2
45
101
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.5
13.2
112
495
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.3
13.1
49
121
R5140
NOMESCO Finland
Monitoring the use of the aid
2.7
13.1
97
398
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
6.8
12.9
32
49
N06AX21
ATC
duloxetine; oral
2.9
12.7
81
302
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.3
12.7
121
568
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
3.8
12.6
53
146
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
4.5
12.6
44
102
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.0
12.6
176
981
A10BX07
ATC
[U] liraglutide; parenteral
10.3
12.6
24
24
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.5
12.5
58
174
A10BG03
ATC
pioglitazone; oral
5.4
12.4
37
72
XF600
NOMESCO Finland
Bloodpressure measurement
3.3
12.2
62
199
SPAT1263
SPAT
Sampling
1.8
12.1
304
2081
I20.00
ICD-10 Finland
Unstable angina
5.7
12.1
34
62
N06AB04
ATC
citalopram; systemic
2.0
12.0
165
912
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
4.0
12.0
47
122
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.2
11.9
64
215
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.4
11.8
57
176
EBA00
NOMESCO Finland
Extraction of tooth
1.8
11.6
243
1560
WX110
NOMESCO Finland
Local anesthesy
1.7
11.6
482
3824
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
7.3
11.6
27
38
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.2
11.5
60
197
L17
ICPC
Foot/toe symptom/complaint
1.9
11.5
183
1067
E66.9
ICD-10 Finland
Obesity, unspecified
5.7
11.4
32
58
S97
ICPC
Chronic ulcer skin
3.4
11.4
55
170
C02AC05
ATC
moxonidine; oral
4.0
11.4
45
118
N05CF01
ATC
zopiclone; oral
1.8
11.3
229
1457
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.6
11.2
84
348
A10BD07
ATC
metformin and sitagliptin; systemic
3.6
11.1
49
141
P01AB01
ATC
metronidazole; oral, rectal
1.8
10.9
262
1756
Z71.8
ICD-10 Finland
Other specified counselling
2.0
10.9
160
903
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
10.8
286
1972
A28
ICPC
Limited function/disability NOS
2.2
10.8
118
588
SPAT1254
SPAT
Administration of medicine
2.2
10.8
112
547
N03AX09
ATC
lamotrigine; oral
4.3
10.8
39
94
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
2.1
10.8
130
675
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
6.9
10.7
26
39
M79.6
ICD-10 Finland
Pain in limb
1.8
10.7
240
1569
K85
ICD-10 Finland
Acute pancreatitis
5.6
10.7
30
55
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
3.0
10.6
61
214
J01MA02
ATC
ciprofloxacin; systemic
1.7
10.6
290
2016
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.7
10.6
364
2705
E66.8
ICD-10 Finland
Other obesity
3.9
10.6
43
116
E78.40
ICD-10 Finland
Familial combined hyperlipidaemia
111.5
10.4
11
*
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.6
10.4
78
321
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
5.9
10.4
28
49
SPAT1310
SPAT
Counselling related to known health issue
1.8
10.3
225
1457
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.1
10.2
122
633
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
10.2
257
1741
A46
ICD-10 Finland
Erysipelas
2.1
10.1
114
578
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
10.1
113
568
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
4.8
9.9
32
69
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
6.4
9.9
25
40
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
9.9
126
671
J01FF01
ATC
clindamycin; systemic
1.8
9.8
194
1214
C09CA06
ATC
candesartan; oral
1.9
9.8
152
871
XCK10
NOMESCO Finland
Photography of fundus of eye
2.4
9.8
83
366
N05BA04
ATC
oxazepam; oral
1.9
9.7
170
1019
N05AH04
ATC
quetiapine; oral
2.1
9.7
115
594
S18
ICPC
Laceration/cut
1.7
9.7
301
2155
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.3
9.7
95
450
C09CA01
ATC
losartan; oral
1.9
9.7
174
1053
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
3.6
9.6
43
126
SPAT1240
SPAT
Therapeutic discussion
2.6
9.6
71
292
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.2
9.5
50
166
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.1
9.5
117
612
K02.1
ICD-10 Finland
Caries of dentine
1.6
9.5
385
2954
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
9.4
195
1237
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
3.6
9.4
41
118
E87.2
ICD-10 Finland
Acidosis
+∞
9.4
9
*
N06AA09
ATC
amitriptyline; systemic
2.5
9.3
75
322
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.5
9.3
32
74
162
Kela drug reimbursment
liraglutide
9.7
9.3
18
19
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
9.2
192
1218
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
7.9
9.2
20
26
R55
ICD-10 Finland
Syncope and collapse
2.3
9.2
85
393
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.4
9.2
82
372
UJF32
NOMESCO Finland
Coloscopy
1.8
9.1
188
1186
FN1BT
NOMESCO Finland
Extensive endovascular dilatation of coronary (PTCA) arteries
6.0
9.1
24
41
82
HP
Single vessel balloon catheter extension
5.7
9.1
25
45
R53
ICD-10 Finland
Malaise and fatigue
1.9
9.1
135
762
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.6
9.1
380
2927
D64.9
ICD-10 Finland
Anaemia, unspecified
2.3
9.0
81
368
A02BC01
ATC
omeprazole; systemic
1.8
9.0
194
1242
E87.5
ICD-10 Finland
Hyperkalaemia
24.3
8.9
12
5
C08CA02
ATC
felodipine; oral
2.4
8.9
76
338
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.2
8.9
90
433
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
8.1
8.9
19
24
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
2.1
8.9
109
571
A02BC05
ATC
esomeprazole; systemic
1.6
8.9
277
1973
B01AC24
ATC
ticagrelor; oral
4.0
8.8
34
88
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.3
8.8
83
388
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
5.0
8.8
27
56
C09BA02
ATC
enalapril and diuretics; systemic
2.4
8.7
74
326
WX722
NOMESCO Finland
PEEP
3.3
8.7
42
132
N18.8
ICD-10 Finland
Other chronic renal failure
4.9
8.6
27
57
PEF23
NOMESCO Finland
Thrombendarterectomy of femoral artery
8.4
8.6
18
22
C10BA02
ATC
simvastatin and ezetimibe; oral, topical
8.4
8.6
18
22
I50.0
ICD-10 Finland
Congestive heart failure
2.7
8.6
59
233
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.6
8.6
61
244
B01AA03
ATC
warfarin; systemic
1.9
8.6
146
863
4019X
ICD-9 Finland
Essential hypertension, Unspecified
4.1
8.5
32
81
A06AD11
ATC
lactulose; oral
2.1
8.5
105
552
A10AE06
ATC
insulin degludec; parenteral
4.5
8.5
29
67
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.2
8.5
87
420
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
2.9
8.5
50
180
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.1
8.5
94
472
C10AC02
ATC
colestipol; oral
91.0
8.4
9
*
280
Kela drug reimbursment
Clopidogrel
8.0
8.4
18
23
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
8.0
8.4
18
23
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
8.4
171
1073
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
2.1
8.3
101
525
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.7
8.3
56
218
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.0
8.3
103
543
A02BA02
ATC
ranitidine; systemic
1.8
8.3
145
866
E0000UV
ATC
NA
1.6
8.2
251
1766
R02
ICPC
Shortness of breath/dyspnoea
2.2
8.2
84
407
N06AX11
ATC
mirtazapine; oral
1.7
8.2
210
1411
A10AB06
ATC
insulin glulisine; parenteral
7.7
8.2
18
24
C07AG02
ATC
carvedilol; oral
2.8
8.2
52
196
R03AC02
ATC
salbutamol; inhalant
1.6
8.2
339
2582
R60.0
ICD-10 Finland
Localized oedema
2.3
8.1
75
344
207
Kela drug reimbursment
Chronic arrhythmias
2.0
8.1
104
555
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
3.5
8.1
36
106
TK800
NOMESCO Finland
Hemodialysis
5.1
8.1
24
48
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.5
8.1
61
252
R11
ICD-10 Finland
Nausea and vomiting
2.7
8.1
55
216
XF402
NOMESCO Finland
ECG with work load test
2.2
8.0
82
396
A01
ICPC
Pain general/multiple sites
2.6
8.0
58
237
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
4.1
7.9
29
72
J01AA02
ATC
doxycycline; systemic
1.6
7.9
536
4584
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
2.1
7.9
90
456
JN3AD
NOMESCO Finland
Abdominal CT examination
2.5
7.9
63
269
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
7.9
466
3848
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.0
7.9
106
577
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.6
7.8
322
2439
H03AA01
ATC
levothyroxine sodium; systemic
1.8
7.8
133
784
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.6
7.8
57
234
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.1
7.8
89
453
SPAT1260
SPAT
Consultation of another employee
1.9
7.7
124
716
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
7.5
7.7
17
23
N06AX16
ATC
venlafaxine; oral
2.1
7.6
88
448
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
5.0
7.6
23
47
P99
ICPC
Psychological disorders other
4.7
7.6
24
52
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
7.6
85
427
WX892
NOMESCO Finland
Monitored bed care
2.6
7.6
55
224
K85.8
ICD-10 Finland
Other acute pancreatitis
10.2
7.6
14
14
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
4.2
7.6
27
66
N07BA03
ATC
varenicline; oral
2.9
7.5
45
164
WX872
NOMESCO Finland
Intensive care
2.8
7.5
45
165
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.7
7.4
197
1329
AN2
HP
Balloon angioplasty, including several vessels
4.0
7.4
28
72
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
5.4
7.4
21
40
J01DA01
ATC
[U] cefalexin; systemic
1.5
7.4
420
3415
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
7.4
116
664
XF404
NOMESCO Finland
Ambulatory ECG
2.3
7.3
70
327
R51.80
ICD-10 Finland
Headache
2.0
7.3
90
471
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.0
7.3
88
458
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
9.5
7.3
14
15
H3603, E113
ICD-10 Finland
NA
9.5
7.3
14
15
2721A
ICD-9 Finland
Disorders of lipoid metabolism, Pure hyperglyceridaemia[HYPERTRIGLYCERIDAEMIA FAMILIARIS (FHT)]
+∞
7.3
7
*
E78.3
ICD-10 Finland
Hyperchylomicronaemia
+∞
7.3
7
*
E78.21
ICD-10 Finland
Remnant hyperlipidemia
+∞
7.3
7
*
T82
ICPC
Obesity
4.2
7.2
26
64
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
3.7
7.2
30
84
PE1BT
NOMESCO Finland
Femoral artery extensive PTA
15.9
7.2
11
7
C10AA02
ATC
lovastatin; oral
3.3
7.2
35
111
SPAT1216
SPAT
Assessment of functional ability
1.9
7.2
106
593
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.6
7.2
50
199
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
7.2
330
2546
N05AX08
ATC
risperidone; systemic
2.4
7.2
62
277
M01AB05
ATC
diclofenac; systemic, rectal
1.5
7.2
456
3787
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.4
7.1
61
270
C07AB08
ATC
celiprolol; oral
4.0
7.1
27
70
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.2
7.1
71
339
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.2
7.1
36
118
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.0
7.1
90
478
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.4
7.1
56
241
K22
ICPC
Risk factor cardiovascular disease
2.7
7.0
45
171
A10BH02
ATC
vildagliptin; oral
4.5
7.0
23
52
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.6
7.0
48
189
SPAT1099
SPAT
Measurement of blood pressure with Doppler ultrasound device
3.5
7.0
30
87
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
4.3
7.0
24
57
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
3.7
6.9
28
77
N03AG01
ATC
valproic acid; systemic, rectal
2.6
6.9
48
191
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.3
6.9
62
281
FN2AB
NOMESCO Finland
Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon
6.8
6.8
16
24
H36.01
ICD-10 Finland
Diabetic maculopathy
5.7
6.8
18
32
B04AC01
ATC
NA
40.4
6.8
8
*
G63.2
ICD-10 Finland
Diabetic polyneuropathy
16.9
6.8
10
6
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
4.2
6.7
24
59
T89
ICPC
Diabetes insulin dependent
3.2
6.7
33
106
E66.0
ICD-10 Finland
Obesity due to excess calories
7.3
6.7
15
21
D01
ICPC
Abdominal pain/cramps general
2.2
6.7
68
329
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
3.6
6.7
28
80
A04
ICPC
Weakness/tiredness general
2.1
6.6
77
395
A10BG02
ATC
rosiglitazone; oral
6.0
6.6
17
29
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.3
6.6
59
270
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
6.6
113
667
SPAT1097
SPAT
Recording of ECG
1.9
6.6
106
612
WX290
NOMESCO Finland
Other blockade of nerve
1.5
6.5
274
2063
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
3.4
6.5
29
87
M01AB01
ATC
indometacin; systemic, rectal
2.2
6.5
63
300
N02AA05
ATC
oxycodone; systemic
1.9
6.5
102
586
SPAT1312
SPAT
General health counselling
1.6
6.5
210
1486
F34.1
ICD-10 Finland
Dysthymia
3.6
6.5
27
77
B01AF02
ATC
apixaban; oral
2.2
6.4
65
315
A11
ICPC
Chest pain NOS
2.4
6.4
54
238
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.4
6.4
51
218
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
2.7
6.4
42
164
SPAT1211
SPAT
Application of soft bandage
2.1
6.4
68
335
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
6.6
6.4
15
23
K92
ICPC
Atherosclerosis/periph vascular dis
6.6
6.4
15
23
I35.0
ICD-10 Finland
Aortic (valve) stenosis
2.5
6.4
48
201
Z72.0
ICD-10 Finland
Tobacco use
4.2
6.4
22
53
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
6.3
255
1901
SPAT1360
SPAT
Extensive global examination
2.3
6.3
57
263
B01AB05
ATC
enoxaparin; parenteral
1.6
6.3
199
1402
S29
ICPC
Skin symptom/complaint other
1.8
6.3
114
689
A10BX04
ATC
[U] exenatide; parenteral
7.1
6.2
14
20
N06AX12
ATC
bupropion; oral
2.7
6.2
40
152
R05
ICPC
Cough
1.7
6.2
140
899
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
6.2
120
737
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.5
6.2
45
186
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.5
6.2
268
2027
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
2.2
6.2
61
293
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
6.4
6.2
15
24
Z13.1
ICD-10 Finland
Special screening examination for diabetes mellitus
5.4
6.2
17
32
SPAT1299
SPAT
Other function in accordance with podiatry nomenclature
5.4
6.2
17
32
N05BA12
ATC
alprazolam; oral
2.0
6.2
73
375
I95.1
ICD-10 Finland
Orthostatic hypotension
3.6
6.2
26
75
FN1CB
NOMESCO Finland
Coronary flow reserve measurement with pressure wire
4.7
6.1
19
41
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
2.8
6.1
36
131
N05BA01
ATC
diazepam; systemic, rectal
1.9
6.1
92
520
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
12.6
6.1
10
8
127
Kela drug reimbursment
Transplant complication
5.6
6.0
16
29

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3012516) Albumin [Mass/volume] in Urine
434
1840
3.89
80.83
4.4
3.1
mg/l
160.8
231.2
0.26
326
1170
(3020682) Albumin/Creatinine [Ratio] in Urine
447
1948
3.85
79.55
5.5
3.8
mg/mmol
13.4
6.8
1.80
342
1223
(3009508) Creatinine [Moles/volume] in Urine
438
1953
3.67
73.82
4.5
3.1
mmol/l
7.6
8.0
1.15
386
1621
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
397
1814
3.30
61.49
2.9
2.0
u/l
321.8
240.6
0.23
373
1696
(3013826) Glucose [Moles/volume] in Serum or Plasma
588
3703
3.08
46.78
7.9
4.3
mmol/l
7.6
6.7
13.29
563
3470
(3032080) INR in Blood by Coagulation assay
453
2586
2.68
41.73
9.7
8.8
inr
1.2
1.3
1.77
121
736
(3020779) Urea [Moles/volume] in Serum or Plasma
156
506
3.57
40.14
10.9
6.7
mmol/l
11.2
9.7
1.58
151
482
(3002032) Base excess in Venous blood by calculation
161
541
3.46
39.16
4.9
3.5
mmol/l
1.5
2.1
1.23
130
423
(3024561) Albumin [Mass/volume] in Serum or Plasma
449
2628
2.57
38.13
7.4
4.6
g/l
35.7
35.5
0.28
416
2419
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
489
3035
2.51
35.79
12.0
6.0
mmol/l
1.2
1.2
0.88
433
2559
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
357
1959
2.46
33.71
3.5
2.4
u/l
52.6
57.7
0.90
330
1810
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
352
1947
2.42
32.33
4.0
3.3
u/l
32.8
33.2
0.12
335
1846
(3023368) Bacteria identified in Blood by Culture
325
1744
2.43
31.84
6.0
4.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
499
3245
2.37
31.17
7.5
6.4
umol/l
10.7
11.9
2.21
476
3082
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
331
1808
2.39
30.97
4.0
2.9
ng/l
2038.5
1273.4
1.03
298
1531
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
400
2388
2.32
30.26
5.1
3.2
ng/l
44.2
59.5
0.38
307
1693
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
658
4891
2.75
29.98
10.3
7.3
u/l
81.7
77.8
1.37
633
4562
(3004789) Transferrin [Mass/volume] in Serum or Plasma
192
827
2.73
29.57
3.6
2.2
g/l
2.4
2.3
1.48
179
771
(3022948) Iron [Moles/volume] in Serum or Plasma
203
903
2.66
29.30
3.6
2.3
umol/l
11.9
13.5
2.66
190
849
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
440
2760
2.28
29.25
10.3
5.3
mmol/l
1.2
1.2
0.34
404
2479
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
114
371
3.41
28.74
4.8
3.5
mmol/l
1.2
1.9
1.02
81
283
(3009343) pH of Capillary blood
117
388
3.35
28.62
4.8
3.5
ph
7.4
7.4
0.78
14
53
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
118
397
3.30
28.18
4.9
3.5
kpa
5.0
5.2
1.25
107
371
(3024354) Oxygen [Partial pressure] in Venous blood
131
475
3.09
27.58
3.4
2.8
kpa
4.9
4.5
1.08
126
463
(3018677) aPTT in Platelet poor plasma by Coagulation assay
198
895
2.60
27.49
2.6
2.1
s
30.4
29.9
0.37
193
862
(3003458) Phosphate [Moles/volume] in Serum or Plasma
172
731
2.71
26.99
11.4
5.6
mmol/l
1.1
1.0
5.10
157
672
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
179
779
2.66
26.78
3.7
2.3
%
20.1
23.6
2.83
158
678
(3036481) Cortisol [Moles/volume] in Serum or Plasma
129
472
3.06
26.69
2.1
2.2
nmol/l
345.9
360.0
0.27
116
437
(3026493) Urate [Moles/volume] in Serum or Plasma
299
1649
2.28
26.49
3.9
2.6
umol/l
3249.3
6432.8
0.85
260
1417
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
90
267
3.66
26.07
5.3
4.4
mmol/l
23.4
24.1
1.18
82
240
(42870588) Differential panel, method unspecified - Blood
346
2056
2.18
25.22
6.8
6.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
402
2539
2.14
24.97
2.4
1.9
pmol/l
97.5
94.7
0.44
219
1318
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
57
124
4.87
24.88
1.3
1.9
nmol/l
1.2
0.8
2.08
46
104
(3027945) Reticulocytes/100 erythrocytes in Blood
158
686
2.61
23.52
3.1
2.9
%
2.1
1.8
1.81
139
628
(3023520) Reticulocytes [#/volume] in Blood
130
518
2.79
22.87
2.7
3.2
e9/l
73.7
69.0
0.74
96
402
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
242
1287
2.25
22.84
2.0
1.7
mg/l
1.0
1.3
1.22
194
972
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
374
2359
2.08
22.67
2.8
2.1
nmol/l
69.2
77.5
6.48
336
2077
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
268
1492
2.18
22.53
2.6
2.1
mg/l
3.0
3.1
0.17
232
1272
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
224
1164
2.27
22.29
5.8
3.6
ng/l
165.0
448.1
2.00
183
912
(3018010) Neutrophils/100 leukocytes in Blood
439
2948
2.05
22.28
6.9
5.9
%
58.8
57.2
2.09
420
2771
(3022096) Basophils/100 leukocytes in Blood
424
2813
2.05
22.24
7.3
6.0
%
0.7
0.7
0.09
400
2627
(3002030) Lymphocytes/100 leukocytes in Blood
443
2988
2.05
22.17
7.4
6.1
%
26.7
27.7
1.17
422
2784
(3019069) Monocytes/100 leukocytes in Blood
435
2923
2.04
21.91
7.5
6.3
%
8.5
8.8
1.44
413
2743
(3006504) Eosinophils/100 leukocytes in Blood
433
2907
2.04
21.84
7.2
6.0
%
2.9
2.9
0.01
409
2713
(3000991) Gas panel - Venous blood
122
486
2.77
21.41
11.0
8.0
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
27
32
8.69
21.11
1.7
1.4
nmol/l
1.2
1.0
0.29
18
24
(3019309) Folate [Moles/volume] in Red Blood Cells
222
1177
2.22
20.86
1.8
1.7
nmol/l
1060.1
1189.8
1.42
171
884
(3003396) Base excess in Arterial blood by calculation
151
688
2.46
20.10
11.1
7.0
mmol/l
1.3
1.2
0.13
119
509
(3007853) Bacteria identified in Skin by Aerobe culture
156
728
2.41
19.67
2.4
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
57
150
4.01
19.51
2.9
2.4
ug/min
166.0
74.0
0.48
38
86
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
102
388
2.86
19.46
5.7
3.6
ng/l
128.9
88.7
2.52
87
339
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
192
988
2.23
19.24
2.1
1.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
591
4547
2.07
19.16
4.8
3.5
pmol/l
14.8
14.9
0.48
542
4079
(3027801) Oxygen [Partial pressure] in Arterial blood
149
690
2.42
19.08
11.2
6.9
kpa
10.8
12.1
3.65
143
659
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
149
690
2.42
19.08
11.2
6.9
kpa
5.1
5.1
0.30
144
656
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
82
280
3.14
18.91
2.6
3.2
pmol/l
4.2
4.5
1.66
68
246
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
689
5642
2.38
18.82
6.1
4.2
mu/l
1.9
1.9
0.37
643
5082
(3037467) Urinalysis macro (dipstick) panel - Urine
570
4345
2.02
18.74
6.1
4.0
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
124
532
2.57
18.67
8.1
6.4
mmol/l
1.5
1.4
0.33
117
513
(3014576) Chloride [Moles/volume] in Serum or Plasma
158
764
2.32
18.29
8.8
6.0
mmol/l
104.1
104.5
0.31
150
750
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
43
97
4.62
17.95
1.1
1.1
iu/ml
6.5
106.8
—
10
23
(3012095) Magnesium [Moles/volume] in Serum or Plasma
179
919
2.21
17.92
4.9
3.6
mmol/l
0.8
0.8
3.30
170
865
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
24
31
7.95
17.49
1.7
1.4
g/l
1.1
1.0
0.42
24
31
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
715
6009
2.48
17.40
10.7
5.4
mmol/mol
46.1
39.6
33.51
673
5525
(3022217) INR in Platelet poor plasma by Coagulation assay
161
803
2.25
17.24
30.2
24.2
inr
1.3
1.3
0.32
27
122
(3018418) pH of Serum or Plasma
288
1785
1.95
17.18
5.5
3.6
ph
7.4
7.4
0.90
54
347
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
73
248
3.13
16.96
6.0
3.9
mmol/l
24.0
25.0
2.31
65
238
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
546
4171
1.92
16.93
5.0
3.1
u/l
77.7
49.3
5.64
515
3879
(3022313) Gas panel - Capillary blood
80
287
2.98
16.92
5.4
3.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
46
115
4.18
16.86
3.8
2.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
116
506
2.51
16.80
3.5
2.8
ng/l
245.3
190.6
0.51
103
459
(3013512) EKG study
300
1898
1.92
16.74
5.1
3.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
445
3194
1.86
16.67
7.5
6.1
e9/l
0.2
0.2
1.61
405
2837
(3031040) Bacteria [#/volume] in Urine by Automated count
535
4084
1.89
16.34
6.0
4.2
e6/l
18.0
2756.7
1.36
13
53
(3021960) Folate [Moles/volume] in Serum or Plasma
242
1435
1.97
16.29
1.8
1.5
nmol/l
21.4
20.9
0.20
215
1208
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
62
196
3.34
16.20
2.6
2.3
ug/l
265.5
484.9
0.46
62
183
(3001122) Ferritin [Mass/volume] in Serum or Plasma
362
2463
1.84
15.86
4.0
2.5
ug/l
173.5
155.3
0.44
334
2251
(3019198) Lymphocytes [#/volume] in Blood
439
3179
1.82
15.58
7.1
5.8
e9/l
2.0
2.0
0.13
399
2827
(3001604) Monocytes [#/volume] in Blood
430
3095
1.82
15.57
7.1
5.7
e9/l
0.6
0.6
2.52
382
2697
(3006315) Basophils [#/volume] in Blood
431
3107
1.82
15.50
7.1
5.8
e9/l
0.0
0.0
1.40
387
2714
(3026782) Osmolality of Urine
215
1243
1.99
15.45
3.9
2.6
mosm/kgh2o
534.8
574.9
1.71
190
1058
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
344
2323
1.83
15.30
4.8
3.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
171
914
2.10
15.23
2.9
2.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
480
3589
1.81
15.14
11.3
9.2
e9/l
4.7
4.1
4.95
422
3168
(3002582) Erythrocytes [#/volume] in Urine
297
1925
1.85
15.02
4.7
3.0
e6/l
49.2
96.0
0.66
252
1510
(3000850) Epithelial cells [#/volume] in Urine
225
1335
1.94
14.93
3.2
2.3
e6/l
5.0
4.8
0.09
207
1184
(3018095) Leukocytes [#/volume] in Urine
326
2208
1.79
14.05
5.5
3.4
e6/l
87.8
85.8
0.02
258
1624
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
139
708
2.16
13.94
3.8
2.7
umol/l
6.8
9.5
1.27
122
625
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
75
289
2.76
13.89
11.0
9.7
mmol/l
24.2
24.4
0.19
70
272
(3026008) Bacteria identified in Urine by Culture
265
1692
1.84
13.85
4.5
3.0
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
136
693
2.15
13.61
3.8
4.8
u/l
226.2
240.6
1.01
126
663
(3013707) Erythrocyte sedimentation rate by Westergren method
577
4643
1.82
13.40
5.0
3.9
mm/h
16.7
11.9
7.54
533
4270
(3044640) Blood type and Crossmatch panel - Blood
291
1927
1.79
13.39
3.4
2.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
268
1732
1.81
13.38
2.2
1.6
mmol/l
3.9
1.4
14.03
241
1421
(3015235) Bicarbonate [Moles/volume] in Capillary blood
50
157
3.33
13.21
2.9
2.8
mmol/l
23.8
25.0
1.00
42
130
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
711
6147
2.18
13.09
7.0
3.8
mmol/l
3.0
1.3
41.34
660
5567
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
215
1307
1.87
13.02
1.9
1.7
pmol/l
22727653.5
24790734.9
0.03
176
1073
(3033658) Prothrombin time (PT) actual/Normal
242
1532
1.82
12.84
6.4
3.9
%
91.9
88.2
1.25
232
1505
(3003181) Sodium [Moles/volume] in Urine
30
67
4.61
12.68
1.3
1.2
mmol/l
58.8
69.3
0.59
22
53
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
730
6397
2.29
12.67
26.3
13.1
mg/l
25.0
25.6
0.19
655
5016
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
94
427
2.36
12.36
1.9
1.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
754
6715
2.53
12.32
32.3
14.9
mmol/l
139.1
139.7
8.73
742
6517
(3023103) Potassium [Moles/volume] in Serum or Plasma
755
6736
2.52
12.14
32.8
15.0
mmol/l
4.0
4.0
0.50
743
6529
(3037522) Nuclear Ab [Titer] in Serum
142
767
2.03
12.10
1.4
1.4
titre
445.3
440.7
0.02
30
161
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
107
522
2.21
11.88
2.8
2.3
ug/l
4.4
7.5
2.46
95
466
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
718
6289
2.14
11.84
6.8
4.4
mmol/l
6.8
6.0
25.55
663
5670
(44816559) Phosphatidylethanol [Mass/volume] in Blood
42
127
3.43
11.78
1.2
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
48
159
3.14
11.64
1.5
1.5
ug/g
275.3
267.9
0.09
25
93
(3040151) Glucose [Moles/volume] in Capillary blood
27
60
4.62
11.49
23.2
4.6
mmol/l
8.3
6.7
1.63
22
50
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
67
270
2.61
11.36
1.8
2.2
g/l
1.7
1.5
1.00
58
237
(1616796) Gas panel - Central venous blood
38
111
3.54
11.23
3.5
3.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
62
242
2.69
11.20
1.9
1.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
392
2926
1.65
11.06
5.6
3.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
257
1721
1.72
10.94
4.3
2.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
721
6370
2.09
10.91
7.6
4.2
mmol/l
1.1
1.4
84.65
675
5798
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
725
6422
2.11
10.84
7.6
4.3
mmol/l
4.4
4.6
5.76
683
5890
(3015377) Calcium [Moles/volume] in Serum or Plasma
293
2045
1.67
10.63
3.7
3.3
mmol/l
2.4
2.3
0.63
244
1768
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
51
186
2.86
10.47
4.6
2.9
u/ml
0.4
0.4
0.13
31
108
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
733
6544
2.13
10.33
8.1
4.7
mmol/l
2.2
2.8
48.55
688
5960
(3030467) Casts [#/volume] in Urine by Automated count
261
1782
1.68
10.22
4.6
2.9
e6/l
0.8
0.5
0.46
215
1368
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
56
220
2.66
10.00
1.8
1.8
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
109
581
2.01
9.55
2.7
2.3
g/l
0.2
0.2
0.72
103
544
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
42
145
3.00
9.52
1.4
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
98
503
2.08
9.51
2.0
2.5
g/l
66.3
66.5
0.13
91
467
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
20
41
4.97
9.35
1.1
1.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
24
58
4.23
9.23
1.5
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
69
311
2.33
9.22
18.0
9.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
84
412
2.16
9.17
1.6
2.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
402
3118
1.57
9.03
4.6
3.4
estimate
0.0
0.0
0.49
67
583
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
122
691
1.90
8.94
2.2
1.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
77
370
2.19
8.85
2.2
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
54
222
2.53
8.82
5.1
4.1
g/l
0.3
0.3
0.16
31
97
(3017143) Hepatitis C virus Ab [Presence] in Serum
113
630
1.92
8.67
1.8
1.6
—
—
—
0
0
(3019225) pH of Specimen
112
623
1.92
8.66
6.8
3.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
221
1502
1.65
8.57
3.2
2.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
121
695
1.87
8.48
2.2
1.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
160
1000
1.75
8.47
4.2
2.8
e6/l
2.6
1.5
0.72
100
571
(3024980) IgG subclass 4 [Mass/volume] in Serum
30
91
3.38
8.41
1.5
1.8
g/l
0.7
0.8
0.29
20
70
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
101
551
1.95
8.26
3.1
2.6
u/l
41.0
32.9
0.34
87
474
(3021601) Nitrite [Presence] in Urine by Test strip
393
3075
1.53
8.22
6.7
4.7
estimate
0.0
0.0
0.00
75
605
(3035350) Ketones [Presence] in Urine by Test strip
393
3076
1.53
8.20
4.6
3.4
estimate
0.0
0.0
0.00
74
604
(40768446) Kidney Pathology biopsy report
12
17
7.15
8.01
1.3
1.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
28
84
3.42
7.99
4.8
2.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
35
122
2.95
7.83
2.0
2.3
g/l
137.7
132.7
0.47
28
91
(3023183) Ammonium ion [Moles/volume] in Plasma
38
139
2.82
7.80
2.7
2.9
umol/l
35.9
36.8
0.08
30
121
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
133
809
1.77
7.70
7.2
4.3
%
26.7
31.6
4.58
103
536
(40758558) Short blood count panel - Blood
217
1513
1.59
7.44
9.4
6.8
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
38
143
2.74
7.41
6.0
5.5
iu/ml
1096.7
368.6
—
10
21
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
131
802
1.75
7.41
2.2
1.9
%
1.5
1.5
0.58
119
699
(3009214) Lutropin [Units/volume] in Serum or Plasma
39
149
2.70
7.39
1.6
1.2
u/l
7.8
8.6
0.19
30
124
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
21
56
3.82
7.11
1.2
1.3
u/l
58.4
45.6
0.87
14
37
(3017181) Myelocytes/100 leukocytes in Blood
94
527
1.89
7.08
4.1
4.7
%
0.6
0.9
0.68
38
160
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
750
6922
1.98
7.05
16.5
9.8
u/l
30.4
27.3
4.78
730
6646
(3021387) Prolactin [Units/volume] in Serum or Plasma
39
155
2.59
6.86
1.5
1.4
mu/l
219.8
282.8
1.22
29
141
(3004775) Volume in Urine collected for unspecified duration
19
50
3.87
6.56
2.1
2.4
ml
586.4
638.7
0.26
14
29
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
54
255
2.20
6.51
1.8
2.0
u/l
33.3
40.0
1.47
47
229
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
161
1077
1.62
6.48
3.8
2.7
e6/l
0.9
0.9
0.13
100
648
(3000494) Fungus identified in Specimen by Culture
120
744
1.72
6.46
1.6
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
32
119
2.76
6.41
2.3
2.4
%
18.1
16.8
0.69
20
62
(3021440) Promyelocytes/100 leukocytes in Blood
88
499
1.86
6.40
4.2
4.9
%
0.1
0.1
0.03
36
144
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
26
86
3.09
6.39
1.0
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
21
61
3.51
6.32
1.3
1.5
nmol/l
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
53
254
2.16
6.17
2.5
2.0
ug/l
4.0
2.5
0.30
46
223
(3008152) Bicarbonate [Moles/volume] in Arterial blood
74
403
1.92
6.09
13.0
6.5
mmol/l
24.7
24.3
0.38
69
377
(3022621) pH of Urine by Test strip
74
403
1.92
6.09
3.2
3.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
24
78
3.14
6.08
2.7
2.4
mmol/l
105.0
105.8
0.31
24
78
(3041354) Potassium [Moles/volume] in Venous blood
24
78
3.14
6.08
2.7
2.4
mmol/l
4.1
4.0
0.15
24
78
(3019060) Gas panel - Arterial blood
76
418
1.90
6.07
10.6
4.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
84
478
1.84
6.04
3.6
4.7
%
0.4
0.4
0.12
25
118
(3028026) IgM [Mass/volume] in Serum or Plasma
70
378
1.93
5.91
1.4
1.6
g/l
1.1
1.4
0.86
65
346
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
21
64
3.34
5.89
1.4
1.5
nmol/l
0.5
0.6
1.39
21
59
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
116
731
1.68
5.87
1.8
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
70
379
1.93
5.87
1.7
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
33
131
2.58
5.85
1.5
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
23
76
3.08
5.68
2.8
2.4
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
27
98
2.81
5.68
3.3
4.4
%
0.4
0.8
0.98
19
83
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
176
1237
1.54
5.67
1.3
1.2
u/ml
0.9
1.6
1.00
41
332
(3017817) Protein [Mass] in Urine collected for unspecified duration
17
46
3.75
5.67
3.7
2.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
42
191
2.26
5.57
2.7
3.3
mg/l
114.7
74.4
0.29
33
154
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
42
191
2.26
5.57
2.7
3.3
mg/l
42.3
49.0
0.16
32
157
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
142
955
1.59
5.54
1.3
1.2
u/ml
14.0
13.6
0.01
50
367
(3005719) IgG [Mass/volume] in Serum or Plasma
83
484
1.80
5.52
1.8
2.8
g/l
10.6
11.0
0.31
74
445
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
24
84
2.91
5.39
1.2
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
14
34
4.17
5.37
1.4
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
14
34
4.17
5.37
1.4
1.5
—
—
—
0
0
(4062490)
18
54
3.39
5.19
1.4
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
19
60
3.22
5.06
1.4
1.5
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
40
186
2.21
5.05
2.8
3.3
ratio
1.4
2.0
—
5
21
(3048929) Epstein Barr virus Ab [Presence] in Serum
41
193
2.18
5.03
1.4
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
28
112
2.55
4.92
2.7
2.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
158
1117
1.51
4.91
1.4
1.4
g/l
2.7
2.6
0.19
95
690
(40760888) Immunoglobulin light chains.free panel - Serum
33
143
2.36
4.90
2.9
3.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
668
6111
1.50
4.85
25.1
12.1
ml/min/173m2
77.4
80.4
2.25
582
5053
(3035637) Corticotropin [Mass/volume] in Plasma
19
62
3.11
4.81
1.4
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
722
6722
1.62
4.80
25.3
12.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
342
2803
1.38
4.71
13.9
9.3
e9/l
0.0
0.0
0.30
286
2308
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
18
58
3.15
4.66
2.6
2.8
—
—
—
0
0
(4146454)
18
58
3.15
4.66
3.7
2.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
41
200
2.11
4.62
2.0
2.5
g/l
0.5
1.5
1.12
35
179
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
38
180
2.17
4.61
2.1
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
78
472
1.72
4.59
3.8
4.9
%
0.0
0.8
0.61
27
125
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
24
554
0.42
4.56
1.5
1.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
223
1708
1.42
4.56
4.6
3.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
29
123
2.41
4.53
4.7
3.9
mmol/l
2.8
2.3
0.24
20
78
(3010421) pH of Blood
34
155
2.25
4.52
5.0
3.5
ph
7.4
7.4
0.84
29
122
(3027135) IgG subclass 1 [Mass/volume] in Serum
17
54
3.19
4.50
1.5
1.5
g/l
6.7
6.5
—
9
37
(3024139) IgG subclass 3 [Mass/volume] in Serum
17
54
3.19
4.50
1.5
1.5
g/l
0.4
0.3
—
9
35
(3028192) IgG subclass 2 [Mass/volume] in Serum
17
54
3.19
4.50
1.5
1.5
g/l
2.8
2.9
—
9
36
(3044927) Protein electrophoresis panel - Urine
19
65
2.97
4.46
1.4
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
57
317
1.86
4.45
2.8
2.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
81
502
1.68
4.38
3.9
2.6
ml/min/173m2
58.9
65.1
0.58
38
186
(3023323) Follitropin [Units/volume] in Serum or Plasma
32
145
2.26
4.33
1.3
1.4
iu/l
18.5
25.7
0.67
25
126
(3036603) Volume of Urine
12
31
3.91
4.27
1.4
1.4
ml
1737.5
1955.0
—
6
5
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
228
1.98
4.24
1.9
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
228
1.98
4.24
1.9
2.4
g/l
7.7
7.3
0.76
33
182
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
228
1.98
4.24
1.9
2.4
g/l
4.0
3.8
0.59
31
176
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
42
214
2.01
4.24
1.9
2.3
g/l
3.0
3.2
0.45
32
179
(3045414) Leukocytes [Presence] in Urine
49
266
1.90
4.13
2.2
1.7
—
—
—
0
0
(4198724)
10
23
4.39
4.09
2.8
1.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
141
1010
1.48
4.08
1.3
1.3
iu/ml
162.4
35.5
0.46
45
304
(3022806) Fractional oxyhemoglobin in Capillary blood
19
69
2.80
4.04
2.3
1.5
%
87.1
90.1
1.46
19
69
(3051387) C reactive protein [Mass/volume] in Capillary blood
29
130
2.28
4.03
3.6
3.7
mg/l
24.7
25.5
0.05
16
85
(3007461) Platelets [#/volume] in Blood
761
7232
1.73
4.03
38.8
19.4
e9/l
246.0
242.8
0.56
743
7010
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
81
514
1.64
4.01
5.0
3.0
mmol/l
1.2
1.2
1.92
72
441
(36660697) Celiac disease serology panel - Serum
72
443
1.69
4.01
1.2
1.1
—
—
—
0
0
(3024731) MCV [Entitic volume]
761
7233
1.72
4.01
38.6
19.3
fl
90.9
91.1
0.64
751
7098
(3035941) MCH [Entitic mass]
761
7234
1.72
3.99
38.6
19.3
pg
30.3
30.4
1.26
750
7097
(3026361) Erythrocytes [#/volume] in Blood
761
7235
1.72
3.98
38.8
19.4
e12/l
4.5
4.6
2.38
742
6993
(3010813) Leukocytes [#/volume] in Blood
761
7236
1.72
3.96
38.9
19.4
e9/l
7.4
6.7
13.25
744
6997
(3000963) Hemoglobin [Mass/volume] in Blood
761
7238
1.71
3.93
39.0
19.5
g/l
134.6
137.7
5.71
749
7101
(3011648) Oxygen content in Venous blood
12
33
3.68
3.93
2.4
1.9
%
11.6
10.8
0.30
12
33
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
10
24
4.21
3.89
2.3
2.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
46
250
1.89
3.88
2.2
3.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
15
6.05
3.82
2.4
3.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
216
1.95
3.79
1.4
2.4
g/l
10.2
10.8
0.34
33
192
(40768797) Stomach Pathology biopsy report
121
853
1.49
3.79
1.2
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
85
559
1.58
3.65
4.4
3.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
30
143
2.14
3.63
1.4
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
55
326
1.74
3.53
1.2
1.2
iu/ml
36.8
130.2
4.71
15
136
(3044889) 12 lead EKG panel
511
4568
1.31
3.50
5.1
3.7
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
15
52
2.92
3.48
1.2
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
23
100
2.34
3.45
1.1
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
15
373
0.39
3.45
1.5
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
36
188
1.96
3.43
1.3
2.3
g/l
38.2
37.3
0.31
31
168
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
27
127
2.16
3.39
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
27
127
2.16
3.39
1.3
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
175
1350
1.38
3.34
4.8
3.7
kg/l
1.0
1.0
0.22
39
189
(3016650) Hepatitis A virus Ab [Presence] in Serum
23
103
2.27
3.25
1.0
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
124
910
1.43
3.16
2.1
1.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
97
679
1.49
3.16
2.5
2.4
ug/g
154.7
137.2
0.27
74
542
(3049717) Cytology report of Urine Cyto stain
47
276
1.75
3.14
2.5
2.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
149
1134
1.38
3.08
3.2
3.1
mmol/l
2.5
2.4
0.44
130
993
(3028707) Methadone [Presence] in Urine by Screen method
19
80
2.41
3.08
4.1
2.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
28
140
2.04
3.03
1.5
1.5
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
7
12
5.87
3.02
1.3
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
108
779
1.45
3.02
1.2
1.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
16
63
2.57
2.97
3.0
4.5
%
63.7
53.8
—
7
48
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
289
2436
1.29
2.94
4.7
3.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
19
82
2.35
2.93
1.6
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
23
108
2.16
2.93
1.3
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
17
4.74
2.92
1.3
1.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
30
3.36
2.91
1.5
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
30
3.36
2.91
1.5
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
17
70
2.46
2.89
1.5
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
27
136
2.02
2.88
1.5
1.3
u/ml
226.5
266.0
0.40
19
80
(3029937) Albumin [Presence] in Urine by Test strip
210
1704
1.31
2.83
4.2
3.7
estimate
0.0
0.0
0.00
69
584
(3044242) Glucose [Moles/volume] in Arterial blood
11
36
3.08
2.81
1.5
3.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
419
3711
1.26
2.81
2.7
2.7
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
14
53
2.67
2.80
1.4
1.9
mmol/l
6.0
6.8
—
8
32
(3009542) Hematocrit [Volume Fraction] of Blood
629
5858
1.32
2.80
28.0
14.1
%
37.8
40.5
5.53
386
4120
(3025941) Bacteria identified in Stool by Culture
51
317
1.65
2.80
1.3
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
24
117
2.08
2.79
4.5
2.9
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
19
84
2.29
2.79
1.6
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
19
84
2.29
2.79
1.6
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
19
84
2.29
2.79
1.6
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
18
78
2.34
2.76
4.3
4.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
49
303
1.66
2.74
6.5
3.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
93
665
1.45
2.73
4.7
3.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
19
85
2.26
2.72
1.6
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
33
183
1.84
2.69
1.3
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
24
119
2.05
2.68
1.4
1.8
—
—
—
0
0
(3017704) Immunofixation for Urine
12
43
2.82
2.65
1.3
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
10
32
3.15
2.65
1.2
1.1
nmol/l
143.0
141.4
—
10
32
(21494890) Protein electrophoresis panel - 24 hour Urine
14
55
2.57
2.62
1.2
1.9
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
9
25
3.63
2.58
3.0
3.7
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
20
4.03
2.57
1.1
1.0
—
—
—
0
0
(4015189)
8
20
4.03
2.57
2.1
2.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
35
201
1.77
2.56
1.6
1.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
63
422
1.53
2.55
2.7
2.7
e9/l
5.2
4.1
1.06
48
326
(3013139) Helicobacter pylori Ag [Presence] in Stool
57
374
1.56
2.53
1.3
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
27
144
1.90
2.49
1.4
1.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
9
26
3.49
2.48
1.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
9
26
3.49
2.48
1.0
1.0
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
11
39
2.85
2.48
1.5
1.5
u/l
4.7
10.0
—
6
18
(1761482) Bacteria [#/volume] in Urine by Culture
30
166
1.84
2.48
8.1
4.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
172
1390
1.30
2.37
4.1
3.5
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
8
22
3.66
2.37
5.6
5.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
8
22
3.66
2.37
3.1
2.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
18
84
2.17
2.36
1.7
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
30
170
1.79
2.31
1.3
1.4
—
—
—
0
0
(4211845)
9
28
3.24
2.31
3.0
3.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
148
1834
0.76
2.29
2.9
3.0
ug/l
1.1
0.7
0.60
93
1213
(40768804) Tissue Pathology biopsy report
280
2410
1.25
2.29
2.2
2.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
22
113
1.97
2.27
2.0
1.9
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
7
18
3.91
2.25
2.6
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
569
5288
1.25
2.25
32.5
16.1
%
14.0
13.7
6.53
560
5165
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
5
9
5.58
2.21
1.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
20
101
2.00
2.17
1.6
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
13
55
2.39
2.13
1.1
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
10
5.02
2.07
7.2
6.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
6
15
4.02
2.04
1.3
1.1
mmol/l
-0.3
3.2
—
6
15
(3021879) Hepatitis B virus core Ab [Presence] in Serum
60
419
1.47
2.04
1.3
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
20
105
1.93
1.97
1.1
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
95
726
1.35
1.94
1.3
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
11
45
2.46
1.93
1.0
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
168
1389
1.26
1.92
4.6
4.6
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
14
65
2.17
1.89
1.2
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
22
3.20
1.88
2.1
6.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
41
269
1.55
1.88
1.3
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
9
34
2.66
1.87
2.1
3.9
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
9
34
2.66
1.87
1.2
1.2
u/l
69.0
87.4
—
9
29
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
17
86
2.00
1.86
1.4
2.8
pg
33.4
32.9
0.17
17
86
(3013727) Leukocytes other/100 leukocytes in Blood
6
17
3.55
1.84
4.3
5.2
%
67.6
48.6
—
6
17
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
31
191
1.65
1.83
1.5
2.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
12
4.19
1.82
1.0
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
35
2.59
1.80
2.1
2.6
u/ml
591.7
1611.0
—
9
35
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
13
3.86
1.71
1.0
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
21
118
1.80
1.71
1.3
1.6
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
23
133
1.75
1.71
1.6
1.5
u/ml
93.3
134.0
—
6
27
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
26
156
1.69
1.71
1.5
1.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
15
75
2.02
1.70
1.3
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
40
581
0.67
1.68
1.4
1.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
6
19
3.17
1.66
2.8
2.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
25
2.81
1.65
1.6
2.3
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
7
25
2.81
1.65
1.0
1.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
25
2.81
1.65
1.6
2.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
25
2.81
1.65
1.6
2.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
25
2.81
1.65
1.6
2.3
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
11
49
2.26
1.64
2.0
1.4
u/l
13.7
13.7
0.00
11
44
(4281824)
11
49
2.26
1.64
1.2
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
24
143
1.70
1.62
3.5
1.9
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
14
3.59
1.61
2.4
1.9
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
14
3.59
1.61
1.2
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
8
32
2.51
1.60
2.5
2.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
13
64
2.05
1.54
1.1
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
14
72
1.96
1.49
4.4
3.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
65
2.02
1.49
2.4
2.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
40
277
1.47
1.47
1.1
1.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
34
228
1.51
1.46
2.3
3.7
u/ml
32.4
5323.4
0.63
27
191
(3052851) Hemolysis interference index of Serum or Plasma
30
196
1.55
1.45
3.6
3.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
12
59
2.05
1.44
1.5
1.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
19
110
1.74
1.44
1.7
1.6
iu/l
2.8
5.9
—
7
31
(3024263) Appearance of Synovial fluid
9
39
2.32
1.43
1.1
1.5
—
—
—
0
0
(3039000) Anion gap in Blood
23
141
1.65
1.43
28.2
6.4
mmol/l
12.7
11.4
1.24
23
125
(3018572) Chloride [Moles/volume] in Blood
23
141
1.65
1.43
28.2
6.4
mmol/l
105.0
105.3
0.12
23
125
(3044941) Cell count panel - Synovial fluid
18
103
1.76
1.41
1.3
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
6
136
0.44
1.41
1.3
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
17
96
1.79
1.39
1.9
2.7
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
9
43
2.10
1.30
6.1
2.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
69
1.90
1.29
1.1
1.1
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
5
18
2.79
1.28
3.4
3.1
umol/l
24.2
27.4
—
5
13
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
18
2.79
1.28
3.4
1.9
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
18
2.79
1.28
3.4
1.9
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
24
154
1.58
1.27
1.6
1.8
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
35
2.30
1.27
2.0
2.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
28
187
1.51
1.25
1.9
1.6
iu/ml
0.0
0.1
—
6
31
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
36
2.23
1.24
4.0
3.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
116
1.65
1.22
1.6
1.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
37
2.17
1.21
1.0
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
25
164
1.54
1.21
1.3
1.2
—
8.6
—
0
6
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
24
156
1.55
1.21
1.3
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
25
165
1.53
1.19
1.6
1.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
12
64
1.89
1.18
1.2
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
11
57
1.94
1.17
1.5
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
11
198
0.55
1.17
1.3
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
11
197
0.55
1.15
1.5
1.7
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
20
2.51
1.15
1.6
1.5
ug/l
71.4
56.3
—
5
20
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
59
459
1.31
1.14
1.8
1.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
79
639
1.26
1.13
1.5
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
25
167
1.51
1.13
1.3
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
7
30
2.34
1.12
1.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
40
2.01
1.12
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
40
2.01
1.12
1.3
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
40
2.01
1.12
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
40
2.01
1.12
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
40
2.01
1.12
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
40
2.01
1.12
1.3
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
15
88
1.72
1.12
1.2
1.2
u/ml
2.4
4.2
—
7
41
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
51
1.97
1.11
1.7
1.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
51
1.97
1.11
1.7
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
51
1.97
1.11
1.7
1.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
108
907
1.22
1.11
1.7
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
7
31
2.27
1.10
1.4
2.3
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
7
31
2.27
1.10
1.7
1.4
u/field
2.4
4.1
—
7
24
(3014051) Protein [Presence] in Urine by Test strip
21
136
1.56
1.09
3.0
1.9
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
21
2.39
1.09
3.4
2.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
21
2.39
1.09
1.8
2.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
21
2.39
1.09
1.8
2.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
80
653
1.25
1.07
3.2
2.2
nmol/l
12.7
14.1
0.79
60
592
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
23
153
1.52
1.07
1.2
1.1
—
7.7
—
0
16
(1002224) Polysomnography panel
35
254
1.39
1.06
1.1
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
7
33
2.13
1.05
1.6
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
69
555
1.27
1.05
4.7
3.6
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
9
46
1.97
1.03
1.1
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
78
638
1.25
1.03
3.5
4.5
ug/l
5.7
32.4
1.32
62
533
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
22
2.28
1.03
1.8
2.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
22
2.28
1.03
1.2
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
19
122
1.57
1.03
3.4
3.5
%
53.9
56.8
0.48
19
122
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
226
2496
0.87
1.02
4.0
4.2
%
24.9
21.2
2.64
104
1210
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
55
433
1.29
1.00
2.4
2.5
—
12.0
—
0
22
(44790047)
14
84
1.68
0.98
1.4
1.7
—
—
—
0
0
(44806118)
14
84
1.68
0.98
1.4
1.7
—
—
—
0
0
(44790049)
14
84
1.68
0.98
1.4
1.7
—
—
—
0
0
(44790048)
14
84
1.68
0.98
1.4
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
331
3071
1.13
0.96
4.5
4.8
ug/l
1.9
3.0
2.01
285
2767
(1617658) Protocol used for examination of sentinel lymph nodes
0
31
0.00
0.96
0.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
32
0.00
0.95
0.0
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
32
0.00
0.95
0.0
1.1
—
9.1
—
0
6
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
15
93
1.62
0.94
1.5
1.6
—
—
—
0
0
(4010399)
57
455
1.27
0.94
1.6
1.4
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
6
27
2.23
0.93
2.5
1.8
umol/l
47.7
46.5
—
6
21
(4024509)
9
52
1.74
0.92
2.2
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
28
2.15
0.91
13.2
15.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
28
2.15
0.91
1.2
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
16
102
1.58
0.91
1.5
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
11
63
1.76
0.90
1.1
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
20
135
1.49
0.89
1.2
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
71
1.70
0.89
1.6
2.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
31
1.94
0.84
1.5
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
31
1.94
0.84
1.0
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
31
1.94
0.84
1.0
1.9
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
98
841
1.19
0.84
8.8
6.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
26
188
1.40
0.84
3.6
1.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
17
113
1.52
0.82
1.8
1.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
24
172
1.41
0.81
3.8
2.0
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
13
81
1.61
0.81
2.1
2.3
mg/l
8.0
26.7
—
5
21
(3020891) Body temperature
34
259
1.33
0.81
5.2
4.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
26
190
1.38
0.80
3.6
1.9
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
17
246
0.68
0.79
1.2
1.6
—
—
—
0
0
(4306422)
13
82
1.59
0.78
1.2
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
99
0.50
0.78
1.6
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
30
226
1.34
0.77
2.4
2.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
17
115
1.49
0.77
1.1
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
15
99
1.52
0.76
1.2
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
9
53
1.71
0.75
1.1
1.1
—
83.3
—
0
9
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
67
1.65
0.75
1.6
2.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
11
67
1.65
0.75
2.2
1.8
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
24
2.09
0.74
1.2
1.5
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
24
2.09
0.74
1.2
1.0
miu/ml
1669.4
1472.1
—
5
24
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
61
507
1.22
0.74
1.9
2.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
192
1751
1.13
0.73
1.3
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
40
1.76
0.71
1.3
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
57
1.59
0.71
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
25
186
1.35
0.70
2.0
2.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
12
77
1.57
0.69
1.3
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
59
1.53
0.68
1.2
1.4
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
7
42
1.67
0.68
1.0
1.5
—
21.3
—
0
8
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
17
119
1.44
0.67
1.3
1.2
—
16.4
—
0
6
(3030905) Polymorphonuclear cells [#/volume] in Blood
17
119
1.44
0.67
3.1
3.2
e9/l
4.6
4.4
0.11
17
119
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
14
94
1.50
0.67
1.5
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
43
1.63
0.67
1.3
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(4094501)
24
180
1.34
0.65
1.1
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
44
1.60
0.65
2.6
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
20
146
1.38
0.64
1.3
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
16
223
0.71
0.63
1.1
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
25
190
1.33
0.63
3.4
1.9
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
30
1.67
0.61
1.0
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
50
1.61
0.61
1.0
1.3
—
—
—
0
0
(4268621)
10
64
1.57
0.58
2.4
2.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
35
1.72
0.57
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
35
1.72
0.57
1.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
35
1.72
0.57
1.0
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
60
1.51
0.54
1.3
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
60
1.51
0.54
1.3
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
13
91
1.44
0.53
2.4
2.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
52
607
0.85
0.53
1.5
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
63
1.43
0.52
1.2
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
100
0.60
0.52
1.3
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
100
0.60
0.52
1.3
1.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
6
40
1.50
0.51
1.5
1.2
mmol/l
1.8
1.9
—
6
40
(3027944) Amphetamines [Presence] in Urine
24
189
1.28
0.50
3.8
1.9
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
67
1.50
0.50
1.7
1.9
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
45
1.56
0.49
1.1
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
45
1.56
0.49
1.1
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
45
1.56
0.49
2.0
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
93
1.40
0.48
1.8
1.5
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
17
128
1.34
0.48
1.2
1.2
—
1.6
—
0
10
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
11
77
1.43
0.45
1.5
1.8
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
6
92
0.65
0.42
1.0
1.1
—
12.9
—
0
7
(3003327) Ova and parasites identified in Stool by Light microscopy
22
176
1.26
0.42
2.0
1.6
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
70
1.43
0.42
1.2
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(4034850)
16
204
0.78
0.39
24.0
9.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
555
5427
1.07
0.39
34.6
16.9
g/l
332.9
333.3
0.41
550
5390
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3000492) Spirometry study
67
601
1.13
0.38
1.7
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
9
68
1.33
0.37
1.1
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
69
1.31
0.37
1.1
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
124
0.72
0.35
1.0
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
43
1.40
0.35
1.2
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
73
1.37
0.34
1.2
1.0
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
6
44
1.37
0.34
1.0
2.5
e9/l
0.1
0.2
—
6
38
(3025130) Human papilloma virus identified in Specimen
6
44
1.37
0.34
1.0
1.6
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
6
46
1.31
0.33
1.2
1.0
mg/l
373.8
262.1
—
6
41
(4035726)
59
533
1.12
0.31
1.3
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
53
1.32
0.31
1.6
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
54
1.30
0.30
1.4
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
35
397
0.88
0.29
2.1
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
85
1.30
0.28
1.0
1.1
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
11
85
1.30
0.28
1.7
1.4
g/l
31.2
32.8
0.11
11
78
(3039162) Centromere protein B Ab [Units/volume] in Serum
10
78
1.29
0.24
1.3
1.2
—
74.5
—
0
5
(4027681)
5
38
1.32
0.23
1.2
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
97
1.24
0.23
1.6
1.7
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
5
41
1.22
0.22
1.0
1.5
—
290.0
—
0
5
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
26.4
—
0
11
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
238
2307
1.04
0.21
5.0
2.7
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
43
1.16
0.21
1.8
1.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
43
1.16
0.21
1.2
1.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
6
48
1.25
0.20
1.7
3.7
u/ml
113.8
60.1
—
6
48
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
50
1.20
0.19
1.5
1.6
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
69
0.72
0.17
4.4
1.9
%
13.4
13.1
—
5
69
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
80
0.75
0.15
1.3
1.9
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
6
80
0.75
0.15
1.7
3.8
u/ml
14.7
28.2
—
6
80
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
23
209
1.10
0.13
2.2
1.7
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
95
1.16
0.11
1.0
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
46
1.09
0.09
4.0
2.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
20
184
1.09
0.09
1.3
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
63
0.79
0.08
1.2
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
63
0.79
0.08
2.0
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
20
185
1.08
0.08
1.3
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
14
127
1.10
0.08
1.6
1.5
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
18
170
1.06
0.04
1.4
1.4
mg/l
546.6
495.7
0.25
18
161
(3020961) Endomysium IgA Ab [Titer] in Serum
25
261
0.96
0.04
1.2
1.1
—
36.0
—
0
5
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
112
1.07
0.03
1.3
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
154
1.04
0.00
1.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
19
184
1.03
0.00
1.3
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
16
157
1.02
0.00
1.1
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
28
282
0.99
0.00
1.2
1.2
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4212803)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
6.7
—
0
5
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
4.9
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
6
64
0.94
0.00
2.0
1.7
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
7
75
0.93
0.00
2.1
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
9
91
0.99
0.00
1.0
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
6
0.00
0.00
0.0
2.3
—
0.7
—
0
6
(3044009) aPTT.lupus sensitive (LA screen)
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
51
0.98
0.00
1.2
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
70
1.00
0.00
4.6
2.8
—
—
—
0
0
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
47
470
1.00
0.00
1.3
1.4
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint E4_HYPERGLYCER and mortality.

Females

Parameter HR [95% CI] p-value
E4_HYPERGLYCER 1.744 [1.49, 2.04] < 0.001
Birth year 0.988 [0.98, 1.0] 0.01

During the follow-up period (1.1.1998 — 31.12.2019), 592 out of 1826 females with E4_HYPERGLYCER died.

Males

Parameter HR [95% CI] p-value
E4_HYPERGLYCER 1.701 [1.46, 1.98] < 0.001
Birth year 0.987 [0.98, 1.0] 0.006

During the follow-up period (1.1.1998 — 31.12.2019), 628 out of 2695 males with E4_HYPERGLYCER died.

Mortality risk

Mortality risk for people of age

years, who have E4_HYPERGLYCER.

N-year risk Females Males
1 0.138% 0.306%
5 0.801% 2.134%
10 1.861% 5.326%
15 3.869% 9.828%
20 6.775% 16.051%

Relationships between endpoints

↥

Index endpoint: E4_HYPERGLYCER – Pure hyperglyceridaemia

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data